Inhibition of the sodium-dependent HCO3- transporter SLC4A4, produces a cystic fibrosis-like airway disease phenotype

  1. Vinciane Saint-Criq
  2. Anita Guequén
  3. Amber R Philp
  4. Sandra Villanueva
  5. Tábata Apablaza
  6. Ignacio Fernández-Moncada
  7. Agustín Mansilla
  8. Livia Delpiano
  9. Iván Ruminot
  10. Cristian Carrasco
  11. Michael A Gray
  12. Carlos A Flores  Is a corresponding author
  1. Université Paris-Saclay, INRAE, France
  2. Centro de Estudios Científicos, Chile
  3. Newcastle University, United Kingdom
  4. Hospital Base Valdivia, Chile

Abstract

Bicarbonate secretion is a fundamental process involved in maintaining acid-base homeostasis. Disruption of bicarbonate entry into airway lumen, as has been observed in cystic fibrosis, produces several defects in lung function due to thick mucus accumulation. Bicarbonate is critical for correct mucin deployment and there is increasing interest in understanding its role in airway physiology, particularly in the initiation of lung disease in children affected by cystic fibrosis, in the absence of detectable bacterial infection. The current model of anion secretion in mammalian airways consists of CFTR and TMEM16A as apical anion exit channels, with limited capacity for bicarbonate transport compared to chloride. However, both channels can couple to SLC26A4 anion exchanger to maximise bicarbonate secretion. Nevertheless, current models lack any details about the identity of the basolateral protein(s) responsible for bicarbonate uptake into airway epithelial cells. We report herein that the electrogenic, sodium-dependent, bicarbonate cotransporter, SLC4A4, is expressed in the basolateral membrane of human and mouse airways, and that it's pharmacological inhibition or genetic silencing reduces bicarbonate secretion. In fully differentiated primary human airway cells cultures, SLC4A4 inhibition induced an acidification of the airways surface liquid and markedly reduced the capacity of cells to recover from an acid load. Studies in the Slc4a4-null mice revealed a previously unreported lung phenotype, characterized by mucus accumulation and reduced mucociliary clearance. Collectively, our results demonstrate that the reduction of SLC4A4 function induced a CF-like phenotype, even when chloride secretion remained intact, highlighting the important role SLC4A4 plays in bicarbonate secretion and mammalian airway function.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file.

Article and author information

Author details

  1. Vinciane Saint-Criq

    Université Paris-Saclay, INRAE, Jouy-en-Josas, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Anita Guequén

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  3. Amber R Philp

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  4. Sandra Villanueva

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  5. Tábata Apablaza

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  6. Ignacio Fernández-Moncada

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  7. Agustín Mansilla

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  8. Livia Delpiano

    Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2319-4456
  9. Iván Ruminot

    Centro de Estudios Científicos, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  10. Cristian Carrasco

    Hospital Base Valdivia, Valdivia, Chile
    Competing interests
    The authors declare that no competing interests exist.
  11. Michael A Gray

    Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Carlos A Flores

    Centro de Estudios Científicos, Valdivia, Chile
    For correspondence
    cflores@cecs.cl
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3813-1909

Funding

CF Trust Strategic Research Centre (SRC003)

  • Michael A Gray

CF Trust Strategic Reserach Centre (SRC013)

  • Michael A Gray

Medical Research Council (MC_PC_15030)

  • Michael A Gray

Fondo Nacional de Desarrollo Científico y Tecnológico (1221257)

  • Carlos A Flores

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Unless otherwise stated, all procedures were performed after mice were deeply anesthetized via i.p. injection of 120 mg/kg ketamine and 16 mg/kg xylazine followed by exsanguination. All experimental procedures were approved by the Centro de Estudios Científicos (CECs) Institutional Animal Care and Use Committee (#2015-02) and are in accordance with relevant guidelines and regulations.

Copyright

© 2022, Saint-Criq et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,524
    views
  • 391
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Vinciane Saint-Criq
  2. Anita Guequén
  3. Amber R Philp
  4. Sandra Villanueva
  5. Tábata Apablaza
  6. Ignacio Fernández-Moncada
  7. Agustín Mansilla
  8. Livia Delpiano
  9. Iván Ruminot
  10. Cristian Carrasco
  11. Michael A Gray
  12. Carlos A Flores
(2022)
Inhibition of the sodium-dependent HCO3- transporter SLC4A4, produces a cystic fibrosis-like airway disease phenotype
eLife 11:e75871.
https://doi.org/10.7554/eLife.75871

Share this article

https://doi.org/10.7554/eLife.75871

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.